Takeda

Cardiff University has formed a partnership with Takeda Pharmaceutical Company Limited (Takeda) for a drug discovery collaboration to identify new approaches for treating schizophrenia and other psychiatric disorders.

The collaboration will combine the University's large scale genomic data and world-class expertise in psychiatric genetics, genomics, clinical and basic neuroscience with Takeda’s extensive drug discovery and clinical development capabilities.

The collaboration will allow Takeda access to world-leading biological psychiatry research and the related infrastructure across the University, including the

• MRC Centre for Neuropsychiatric Genetic and Genomics
• Neuroscience and Mental Health Research Institute
• National Centre for Mental Health
• Brain Repair and Intracranial Neurotherapeutics Unit.

Enquiries

For more information regarding the Takeda partnership, please contact: